BPC-157 is a synthetic 15-amino-acid peptide derived from a protein found in human gastric juice
IGF-1 stimulates the proliferation and differentiation of satellite cells, which are responsible for repairing damaged muscle tissue after exercise or injury
Why it matters: As GLP-1 demand grows, telehealth companies in the weight loss drug space must choose between tie-ups with riskier compounding pharmacies or more stable deals with GLP-1 drugmakers Novo and Eli Lilly
According to recent research in The Lancet , up to 39 percent of the weight people lose on these drugs can come from lean mass
If you meet the medical necessity criteria, such as having a high BMI and related health conditions, and have a history of trying lifestyle changes, your chances are better
This question reflects growing interest in GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound) for chronic weight management